These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 791153)

  • 1. Malignant atrophic papulosis of Degos. Report of a patient who failed to respond to fibrinolytic therapy.
    Howsden SM; Hodge SJ; Herndon JH; Freeman RG
    Arch Dermatol; 1976 Nov; 112(11):1582-8. PubMed ID: 791153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of fibrinolytic treatment in malignant atrophic papulosis.
    Delaney TJ; Black MM
    Br Med J; 1975 Aug; 3(5980):415. PubMed ID: 1156791
    [No Abstract]   [Full Text] [Related]  

  • 3. Malignant atrophic papulosis (Degos' disease).
    Black MM
    Int J Dermatol; 1976; 15(6):405-11. PubMed ID: 1279068
    [No Abstract]   [Full Text] [Related]  

  • 4. Fibrinolytic therapy for vasculitis of atrophie blanche.
    Gilliam JN; Herndon JH; Prystowsky SD
    Arch Dermatol; 1974 May; 109(5):664-7. PubMed ID: 4828532
    [No Abstract]   [Full Text] [Related]  

  • 5. Phenformin and ethyloestrenol in recurrent deep venous thrombosis (DVT).
    Hedner U; Nilsson IM; Isacson S
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1976; 103(3):372-80. PubMed ID: 63424
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical and laboratory double-blind investigation on effect of fibrinolytic therapy in patients with cutaneous vasculitis.
    Dodman B; Cunliffe WJ; Roberts BE; Sibbald R
    Br Med J; 1973 Apr; 2(5858):82-4. PubMed ID: 4573315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An association between cutaneous vasculitis and decreased blood-fibrinolytic activity.
    Cunliffe WJ
    Lancet; 1968 Jun; 1(7554):1226-8. PubMed ID: 4172776
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of phenformin and ethyloestrenol or stanozolol in the treatment of decreased fibrinolytic states. (Cutaneous vasculitis, Raynaud's disease, Behcet's syndrome, recurrent deep vein thrombosis and post myocardial infarction).
    Menon IS
    Acta Univ Carol Med Monogr; 1972; 52():19-23. PubMed ID: 4669824
    [No Abstract]   [Full Text] [Related]  

  • 9. Fibrinolytic activity and coronary-artery disease.
    Naimi S; Proger S
    Lancet; 1968 Jun; 1(7554):1250-1. PubMed ID: 4172804
    [No Abstract]   [Full Text] [Related]  

  • 10. Oral fibrinolytic agents.
    Fearnley GR; Chakrabarti R
    Br Med J; 1968 Aug; 3(5616):498. PubMed ID: 5666808
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of chronic thromboembolism with Arvin, oral fibrinolytics and standard anticoagulants.
    Kounis NG; Evans WH
    Vasc Surg; 1977; 11(2):68-72. PubMed ID: 616136
    [No Abstract]   [Full Text] [Related]  

  • 12. Experiences in the use of fibrinolytic agents in Behcet's syndrome.
    Kirk J; Handley DA
    Australas J Dermatol; 1972 Apr; 13(1):5-10. PubMed ID: 5082495
    [No Abstract]   [Full Text] [Related]  

  • 13. Editorial: Fibrinolysis and venous thrombosis.
    Br Med J; 1974 Nov; 4(5941):365-6. PubMed ID: 4425884
    [No Abstract]   [Full Text] [Related]  

  • 14. Enhancement of fibrinolytic activity.
    Lancet; 1973 Sep; 2(7831):716. PubMed ID: 4125800
    [No Abstract]   [Full Text] [Related]  

  • 15. The association between cutaneous vasculitis and decreased blood fibrinolytic activity.
    Cunliffe WJ; Menon IS
    Br J Dermatol; 1971 Feb; 84(2):99-105. PubMed ID: 4396169
    [No Abstract]   [Full Text] [Related]  

  • 16. Phenformin and stanozolol in blood fibrinolytic activity.
    Menon IS; Cunliffe WJ; Weightman D; Dewar HA
    Br Med J; 1970 Feb; 1(5693):428. PubMed ID: 4244848
    [No Abstract]   [Full Text] [Related]  

  • 17. Failure of colchicine and fibrinolytic therapy in Behçet's disease.
    Graham-Brown RA; Sarkany I
    Clin Exp Dermatol; 1980 Mar; 5(1):87-92. PubMed ID: 7398131
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacological stimulation of fibrinolytic activity in the surgical patient.
    Brown IK; Haggart B; Murray GH; Downie RJ; Littler J; Robb PM; Santer GJ
    Lancet; 1971 Apr; 1(7703):774-6. PubMed ID: 4101274
    [No Abstract]   [Full Text] [Related]  

  • 19. Current trends in the treatment of central venous thrombosis.
    Marmion VJ; Bowell RE
    Trans Ophthalmol Soc U K (1962); 1970; 90():973-6. PubMed ID: 4933934
    [No Abstract]   [Full Text] [Related]  

  • 20. The value of phenformin and ethyloestrenol in the prevention of deep venous thrombosis in patients undergoing surgery.
    Atkins P; Brown IK; Downie RJ; Haggart BG; Littler J; Robb PM; Santer GJ; Jones I
    Thromb Haemost; 1978 Feb; 39(1):89-96. PubMed ID: 580509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.